These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2168912)
1. Serum neuron-specific enolase as a marker of small-cell carcinoma of the esophagus. Sasajima K; Watanabe M; Ando T; Hao K; Miyashita M; Yamashita K; Onda M; Takubo K J Clin Gastroenterol; 1990 Aug; 12(4):384-8. PubMed ID: 2168912 [TBL] [Abstract][Full Text] [Related]
2. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer. Pinson P; Joos G; Watripont P; Brusselle G; Pauwels R Respiration; 1997; 64(1):102-7. PubMed ID: 9044484 [TBL] [Abstract][Full Text] [Related]
3. [Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study]. Emin Erbaycu A; Gunduz A; Batum O; Zeren Ucar Z; Tuksavul F; Zeki Guclu S Arch Bronconeumol; 2010 Jul; 46(7):364-9. PubMed ID: 20537457 [TBL] [Abstract][Full Text] [Related]
4. Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC. Ebert W; Muley T; Trainer C; Dienemann H; Drings P Anticancer Res; 2002; 22(2B):1083-9. PubMed ID: 12168905 [TBL] [Abstract][Full Text] [Related]
5. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma. Fizazi K; Cojean I; Pignon JP; Rixe O; Gatineau M; Hadef S; Arriagada R; Baldeyrou P; Comoy E; Le Chevalier T Cancer; 1998 Mar; 82(6):1049-55. PubMed ID: 9506348 [TBL] [Abstract][Full Text] [Related]
6. [Neuron-specific enolase (NSE) serum level as a prognostic factor in non-small cell lung cancer]. Zych J; Szturmowicz M; Sakowicz A; Słodkowska J; Załeska M; Radzikowska E; Załeska J; Jodkiewicz Z; Rowińska-Zakrzewska E Pneumonol Alergol Pol; 2002; 70(5-6):278-83. PubMed ID: 12518626 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung. Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T Gan; 1983 Apr; 74(2):219-25. PubMed ID: 6305752 [TBL] [Abstract][Full Text] [Related]
8. Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma. van de Pol M; Twijnstra A; ten Velde GP; Menheere PP J Neurooncol; 1994; 19(2):149-54. PubMed ID: 7964990 [TBL] [Abstract][Full Text] [Related]
9. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054 [TBL] [Abstract][Full Text] [Related]
10. [The changes in serum neuron-specific enolase in patients with small cell lung cancer]. Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. Cooper EH; Splinter TA; Brown DA; Muers MF; Peake MD; Pearson SL Br J Cancer; 1985 Sep; 52(3):333-8. PubMed ID: 2994704 [TBL] [Abstract][Full Text] [Related]
12. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer]. Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108 [TBL] [Abstract][Full Text] [Related]
13. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer. Bonner JA; Sloan JA; Rowland KM; Klee GG; Kugler JW; Mailliard JA; Wiesenfeld M; Krook JE; Maksymiuk AW; Shaw EG; Marks RS; Perez EA Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544 [TBL] [Abstract][Full Text] [Related]
14. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer. Jørgensen LG; Hansen HH; Cooper EH Eur J Cancer Clin Oncol; 1989 Jan; 25(1):123-8. PubMed ID: 2537729 [TBL] [Abstract][Full Text] [Related]
15. Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients. Batandier C; Brambilla E; Nagy-Mignotte H; Laporte F; Jacrot M; Beriel H; Paramelle B; Brambilla C Scand J Clin Lab Invest; 1989 Feb; 49(1):33-42. PubMed ID: 2543057 [TBL] [Abstract][Full Text] [Related]
16. Primary small cell carcinoma of the esophagus with achalasia in a patient in whom pro-gastrin-releasing peptide and neuron-specific enolase levels reflected the clinical course during chemotherapy. Suzuki H; Takayanagi S; Otake T; Ishibashi R; Osawa S; Shirai T; Takashima M; Hanai H; Kaneko E J Gastroenterol; 1999 Jun; 34(3):378-82. PubMed ID: 10433016 [TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer]. Moriya H; Hisa S; Satoh T; Suzuki S; Kimura K; Higuchi Y; Hoshi K Rinsho Hoshasen; 1988 Jan; 33(1):31-4. PubMed ID: 2835529 [No Abstract] [Full Text] [Related]
18. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance? Harding M; McAllister J; Hulks G; Vernon D; Monie R; Paul J; Kaye SB Br J Cancer; 1990 Apr; 61(4):605-7. PubMed ID: 2158809 [TBL] [Abstract][Full Text] [Related]
19. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer. Akoun GM; Scarna HM; Milleron BJ; Bénichou MP; Herman DP Chest; 1985 Jan; 87(1):39-43. PubMed ID: 2981171 [TBL] [Abstract][Full Text] [Related]
20. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer. Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]